Free Trial
NASDAQ:DRMAW

Dermata Therapeutics (DRMAW) Stock Price, News & Analysis

$0.02 0.00 (-2.00%)
As of 11:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Dermata Therapeutics Stock (NASDAQ:DRMAW)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.03
Volume
2,635 shs
Average Volume
13,095 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Remove Ads
Receive DRMAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DRMAW Stock News Headlines

See More Headlines

DRMAW Stock Analysis - Frequently Asked Questions

Dermata Therapeutics' stock was trading at $0.0107 at the beginning of the year. Since then, DRMAW shares have increased by 83.2% and is now trading at $0.0196.
View the best growth stocks for 2025 here
.

Shares of DRMAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DRMAW
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:DRMAW) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners